Killer ARDS under-recognised and under-treated
by Bruce Sylvester: Researchers report that about 10 per cent of patients in intensive care units worldwide have Acute Respiratory Distress Syndrome (ARDS), that the mortality rate from… read more.
by Bruce Sylvester: Researchers report that about 10 per cent of patients in intensive care units worldwide have Acute Respiratory Distress Syndrome (ARDS), that the mortality rate from… read more.
by Maria Dalby: Organ donation from children aged less than 2 years is extremely rare in the UK but could offer significant scope for expanding the donor pool…. read more.
by Maria Dalby: Organ donation from children aged less than 2 years is extremely rare in the UK but could offer significant scope for expanding the donor pool…. read more.
Controversies in UK organ transplantation: have we gone too far in terms of organ quantity at the expense of organ quality? John Forsythe, Edinburgh Royal Infirmary and Chris… read more.
Best practice immunosuppression – no more Mr Nice Guy. Nicholas Torpey, Addenbrooke’s Hospital, Cambridge. Overview by Maria Dalby The updated recommendations from the National Institute for Health… read more.
Best practice immunosuppression – no more Mr Nice Guy. Nicholas Torpey, Addenbrooke’s Hospital, Cambridge. Overview by Maria Dalby The updated recommendations from the National Institute for Health… read more.
Organ Allocation: looking to the future. An interview with Lorna Marson (University of Edinburgh) and Professor John O’Grady (Kings College Hospital, London)
by Bruce Sylvester: Among adults with chronic sinusitis and nasal polyps who do not respond to intranasal corticosteroids, addition of investigative dupilumab to mometasone furoate nasal spray compared… read more.
by Bruce Sylvester: Ivacaftor appears to be safe and efficacious for children ages 2 to and 5 with a specific type of cystic fibrosis, researchers reported on Jan…. read more.
by Bruce Sylvester: Researchers report that corticosteroids treatment of mothers at risk for late preterm delivery significantly reduces the incidence of severe respiratory complications in their babies.
by Bruce Sylvester: Researchers report that patients treated with the dementia drug rivastigimine are less likely to fall and are much steadier when walking, compared to patients receiving… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.